Gastrointestinal (GI) cancers, which affect the stomach, colon, pancreas, and other digestive organs, are rising at an alarming rate in...
cancers
Pharma major Novartis on Saturday announced that its drug Lutathera has shown significantly improved patient outcomes for gastroenteropancreatic neuroendocrine tumors....
In a recent study published in The Lancet Gastroenterology and Hepatology, researchers estimated the lifetime risk of gastrointestinal cancer and...